Articles
-
1 month ago |
globalresearch.ca | Richard M. Gale |Gary Null |Stephen Karganovic |Peter Koenig
Do Vaccines Cause Autism? Ask any federal health official—whether from theFDA, CDC, NIH, or National Cancer Institute—if vaccines contribute to neurological damage or autism, and their response will be unequivocal:No, there is no evidence of any association.In fact, they might find the very question offensive.
-
2 months ago |
modernretina.com | John W. Kitchens |Richard M. Gale |Michael Stewart
January 31, 2025By Panelists discuss how faricimab’s bispecific antibody design uniquely targets both VEGF-A and Ang-2 pathways, addressing the complementary role of Ang-2 in vascular destabilization and inflammation in retinal diseases. Video content above is prompted by the following: What is the unique nature of the faricimab molecule, and what is the clinical rationale for targeting Ang-2 in treating retinal diseases? Related Content Related Content
-
Jan 10, 2025 |
modernretina.com | John W. Kitchens |Richard M. Gale |Michael Stewart
Panelists discuss how aflibercept 8 mg demonstrates improved durability and maintenance of visual gains compared with 2-mg dosing, potentially reducing treatment burden while maintaining a similar safety profile.
-
Dec 31, 2024 |
globalresearch.ca | Richard M. Gale
Two weeks ago, president elect Trump stated that he would like to see the US withdraw from the World Health Organization. He cited the disproportionate amount of money the US taxpayer gives to the organization compared with other nations. But where Trump’s reason may be correct, it should not be the main reason for leaving the WHO.
-
Dec 27, 2024 |
globalresearch.ca | Richard M. Gale
Efforts to eradicate polio, once considered a public health triumph, are now threatened by a complex interplay of scientific, logistical, and geopolitical challenges. The emergence of vaccine-derived polioviruses (VDPVs) and a rise in vaccine-related complications have introduced unforeseen obstacles.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →